Key result
In adults with heart failure, the presence of ≥3 noncardiac conditions combined with mobility limitation was associated with a nearly twofold increased risk of all-cause mortality (HR 1.93).
Why the study?
The individual and combined associations of noncardiac-related conditions and mobility limitation with morbidity and mortality in adults with HF needed to be examined.
Does the presence of noncardiac conditions and mobility limitation increase the risk of mortality and hospitalization in adults with heart failure?
Cohort (n=114,553)
Yes
Does the presence of noncardiac conditions and mobility limitation increase the risk of mortality and hospitalization in adults with heart failure?
Hazard Ratio: 1.93 (95% CI 1.85–2.01)
Mobility limitation has an additive association with mortality beyond the burden of noncardiac multimorbidity in patients with heart failure, particularly in younger patients.
Mobility limitation was associated with higher HF mortality beyond multimorbidity; leaves open whether targeted interventions improve outcomes.
BACKGROUND: To examine the individual and combined associations of noncardiac-related conditions and mobility limitation with morbidity and mortality in adults with heart failure (HF). METHODS: We conducted a retrospective cohort study in a large, diverse group of adults with HF from five U.S. integrated healthcare delivery systems. We characterized patients with respect to the presence of noncardiac conditions (<3 vs ≥3) and/or mobility impairment (defined by the use/nonuse of a wheelchair, cane, or walker), categorizing them into four subgroups. Outcomes included all-cause death and hospitalizations for HF or any cause. RESULTS: Among 114,553 adults diagnosed with HF (mean age: 73 years old, 46% women), compared with <3 noncardiac conditions/no mobility limitation, adjusted hazard ratios (HR) for all-cause death among those with <3 noncardiac conditions/mobility limitation, ≥3 noncardiac conditions/no mobility limitation, ≥3 noncardiac conditions/mobility limitation (vs) were 1.40 (95% CI, 1.31-1.51), 1.72 (95% CI, 1.69-1.75), and 1.93 (95% CI, 1.85-2.01), respectively. We did not observe an increased risk of any-cause or HF-related hospitalization related to the presence of mobility limitation among those with a greater burden of noncardiac multimorbidity. Consistent findings regarding mortality were observed within groups defined according to age, gender, and HF type (preserved, reduced, mid-range ejection fraction), with the most prominent impact of mobility limitation in those <65 years of age. CONCLUSIONS: There is an additive association of mobility limitation, beyond the burden of noncardiac multimorbidity, on mortality for patients with HF, and especially prominent in younger patients.
No takes yet. Share an insight, caveat, or question.
Tisminetzky et al. (2019) conducted a cohort in Heart failure (n=114,553). ≥3 noncardiac conditions and mobility limitation vs. <3 noncardiac conditions and no mobility limitation was evaluated on All-cause mortality (HR 1.93, 95% CI 1.85-2.01). In adults with heart failure, the presence of ≥3 noncardiac conditions combined with mobility limitation was associated with a nearly twofold increased risk of all-cause mortality (HR 1.93).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: